Commission Implementing Decision (EU) 2023/460 of 2 March 2023 postponing the expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)
Text
Article-level text, parsed from the formex manifestation.
Article 1
The expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 set out in Annex I to Directive 98/8/EC is postponed to 31 December 2025.
Article 2
This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
Relations
What this act cites, and what cites it.
Show relationsVersions
Point-in-time consolidated versions of this act.
Show versions